Premium
Palliative treatment of skin metastases in dermato‐oncology
Author(s) -
Kähler Katharina C.,
Egberts Friederike,
Gutzmer Ralf
Publication year - 2013
Publication title -
jddg: journal der deutschen dermatologischen gesellschaft
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.463
H-Index - 60
eISSN - 1610-0387
pISSN - 1610-0379
DOI - 10.1111/ddg.12197
Subject(s) - medicine , electrochemotherapy , concomitant , melanoma , chemotherapy , quality of life (healthcare) , radiation therapy , palliative care , oncology , breast cancer , cancer , bleomycin , cancer research , nursing
Summary Patients with metastatic melanoma, but also other solid tumors (e.g., lung or breast cancer), may develop cutaneous metastases in advanced stages. The goal of treatment is to alleviate symptoms such as pain, fetor, secretions, or bleeding. Current treatment modalities are based on a multimodal treatment approach. Beside surgery, treatment options such as electrochemotherapy, isolated limb perfusion, radiotherapy, and local administration of cytokines or chemotherapy agents are available. In case of concomitant visceral metastases, this local treatment approach may not affect overall survival, but the palliation of these tumor‐associated symptoms very often improves the quality of life for the patient.